SGMOQ
Sangamo Therapeutics, Inc
$0.07
0.00 (-5.41%)
At close · Jul 2
Market Cap
$30.66M
Shares
414,288,847
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-01 | 2026-06-24 | |
| 8-K/A | 2026-06-23 | 2026-06-18 | |
| 8-K | 2026-06-23 | 2026-06-18 | |
| 8-K | 2026-05-14 | — | |
| 10-Q | 2026-05-14 | 2026-03-31 | |
| 10-K/A | 2026-04-30 | 2025-12-31 | |
| 8-K | 2026-04-29 | 2026-04-28 | |
| 10-K | 2026-03-30 | 2025-12-31 | |
| 8-K | 2026-03-30 | — | |
| 8-K | 2026-02-04 | 2026-02-03 | |
| 8-K | 2026-02-03 | 2026-02-02 | |
| 8-K | 2026-02-03 | — | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-10-29 | — | |
| 8-K | 2025-09-30 | 2025-09-24 | |
| 8-K | 2025-09-11 | 2025-09-09 | |
| 8-K | 2025-09-04 | — | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-06-24 | — | |
| 8-K | 2025-06-16 | 2025-06-12 | |
| 8-K | 2025-05-13 | 2025-05-12 | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| 8-K | 2025-05-06 | 2025-04-30 | |
| DEF 14A | 2025-04-30 | 2025-06-12 | |
| 10-K | 2025-03-17 | 2024-12-31 | |
| 8-K | 2025-03-17 | — | |
| 8-K | 2025-02-06 | — | |
| 8-K | 2024-12-30 | 2024-12-22 | |
| 8-K | 2024-12-10 | 2024-12-09 | |
| 8-K | 2024-11-12 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-10-04 | — | |
| 8-K | 2024-08-06 | — | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 8-K | 2024-07-24 | — | |
| 8-K | 2024-06-05 | 2024-06-04 | |
| 8-K | 2024-05-09 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-04-30 | 2024-04-24 | |
| DEF 14A | 2024-04-19 | 2024-06-04 | |
| 8-K | 2024-03-25 | 2024-03-21 | |
| 8-K | 2024-03-13 | — | |
| 10-K | 2024-03-13 | 2023-12-31 | |
| 8-K | 2024-02-06 | 2024-02-05 | |
| 8-K | 2024-01-19 | — | |
| 8-K | 2023-12-13 | 2023-12-11 | |
| 8-K | 2023-11-03 | 2023-11-02 | |
| 10-Q | 2023-11-01 | 2023-09-30 |
Showing 1–50 of 123 filings